Therefore, future studies modulating the spinophilin-PP1 complex, or other spinophilin protein interactions could be a novel therapeutic approach for improving metabolic function or restoring obesity-induced dysregulation of metabolic function. Here, PPP1R9B is linked to obesity disorder.